조현병 환자의 생애 특질로서 평가된 증상차원과 인지기능 및 다른 임상 특성의 연관성
Correlation of Lifetime Symptom Dimensions with Cognitive Function and Other Clinical Characteristics in Schizophrenia Patients
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives : Considering large diversity of clinical presentation of schizophrenia, it is important to identify valid clinical subtypes or dimensions that might have homogeneous biological underpinning. The current study aimed to explore lifetime symptom-based dimensional phenotypes in patients with chronic schizophrenia, and to investigate their correlation with cognitive functions and other clinical characteristics. Methods : Lifetime-based symptoms and additional clinical variables were measured using the Diagnostic Interview for Genetic Studies and the Schedule for the Deficit Syndrome in 315 clinically stable patients with chronic schizophrenia. Through principal components factor analysis, eight dimensional phenotypes were obtained. Comprehensive neuropsychological tests were administered for 103 out of 315 patients, and domain scores were calculated for cognitive domains defined in the MATRICS consensus battery. Results : ‘Non-paranoid delusion factor’ including delusions of grandiose or religious nature, showed significant negative correlation with processing speed, working memory, attention/vigilance, and general cognitive ability, and positive correlation with intra-individual variability. ‘Negative symptom factor’ showed significant negative correlation only with general cognitive ability. Those two factors were also negatively correlated with function levels measured by Global Assessment Scale (GAS), and associated with poor treatment responses. Conclusion : Symptom-based dimensional phenotypes of schizophrenia measured on a lifetime basis showed discriminative correlation with cognitive function domains, global functioning level, and overall treatment responses, indicating their possibility as valid phenotype axes of schizophrenia having homogeneous biologic basis.
Abstract
Objectives : Considering large diversity of clinical presentation of schizophrenia, it is important to identify valid clinical subtypes or dimensions that might have homogeneous biological underpinning. The current study aimed to explore lifetime symptom-based dimensional phenotypes in patients with chronic schizophrenia, and to investigate their correlation with cognitive functions and other clinical characteristics. Methods : Lifetime-based symptoms and additional clinical variables were measured using the Diagnostic Interview for Genetic Studies and the Schedule for the Deficit Syndrome in 315 clinically stable patients with chronic schizophrenia. Through principal components factor analysis, eight dimensional phenotypes were obtained. Comprehensive neuropsychological tests were administered for 103 out of 315 patients, and domain scores were calculated for cognitive domains defined in the MATRICS consensus battery. Results : ‘Non-paranoid delusion factor’ including delusions of grandiose or religious nature, showed significant negative correlation with processing speed, working memory, attention/vigilance, and general cognitive ability, and positive correlation with intra-individual variability. ‘Negative symptom factor’ showed significant negative correlation only with general cognitive ability. Those two factors were also negatively correlated with function levels measured by Global Assessment Scale (GAS), and associated with poor treatment responses. Conclusion : Symptom-based dimensional phenotypes of schizophrenia measured on a lifetime basis showed discriminative correlation with cognitive function domains, global functioning level, and overall treatment responses, indicating their possibility as valid phenotype axes of schizophrenia having homogeneous biologic basis.
참고문헌 (53)
- Andreasen NC, "Schizophrenia: the characteristic symptoms", Schizophr Bull, 17, pp.27~49 (1991)
- American Psychiatric Association, "Diagnostic And Statistical Manual Of Mental Disorders" (2000), American Psychiatric Press
- American Psychiatric Association, "Diagnostic And Statistical Man-ual of Mental Disorders" (2013), American Psychiatric Press
- Tandon R, "Definition and description of schizophrenia in the DSM-5", Schizophr Res, 150, pp.3~10 (2013)
- Tandon R, "Schizophrenia, “just the facts”what we know in 2008. 2. Epidemiology and etiology", Schizophr Res, 102, pp.1~18 (2008)
- Bilder RM, "Symptomatic and neuropsychological components of defect states", Schizophr Bull, 11, pp.409~419 (1985)
- Liddle PF, "The symptoms of chronic schizophrenia. A re-examina-tion of the positive-negative dichotomy", Br J Psychiatry, 151, pp.145~151 (1987)
- Andreasen NC, "Symptoms of schizophrenia. Methods, meanings, and mechanisms", Arch Gen Psychiatry, 52, pp.341~351 (1995)
- Peralta V, "Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy", Br J Psychiatry, 161, pp.335~343 (1992)
- Fanous AH, "Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia", Am J Psychiatry, 162, pp.1824~1832 (2005)
- Rietkerk T, "The genetics of symptom dimensions of schizophrenia: review and meta-analysis", Schizophr Res, 102, pp.197~205 (2008)
- Vassos E, "Correlation and familial aggregation of dimensions of psychosis in affected sib-ling pairs from China", Br J Psychiatry, 193, pp.305~310 (2008)
- Wickham H, "Familiality of symptom dimensions in schizophrenia", Schizophr Res, 47, pp.223~232 (2001)
- McGrath JA, "Familiality of novel factorial dimensions of schizophrenia", Arch Gen Psychiatry, 66, pp.591~600 (2009)
- Ryu S, "Genome-wide linkage scan of quantitative traits representing symptom di-mensions in multiplex schizophrenia families", Psychiatry Res, 210, pp.756~760 (2013)
- Elvevag B, "Cognitive impairment in schizophrenia is the core of the disorder", Crit Rev Neurobiol, 14, pp.1~21 (2000)
- Heinrichs RW, "Neurocognitive deficit in schizophre-nia: a quantitative review of the evidence", Neuropsychology, 12, pp.426~445 (1998)
- Buchanan RW, "A summary of the FDA-NIMH-MATRICS workshop on clini-cal trial design for neurocognitive drugs for schizophrenia", Schizophr Bull, 31, pp.5~19 (2005)
- Bora E, "Meta-analysis of Cognitive Deficits in Ultra-high Risk to Psychosis and First-Episode Psychosis: Do the Cogni-tive Deficits Progress Over, or After, the Onset of Psychosis?", Schizophr Bull, 40, pp.744~755 (2014)
- Cornblatt BA, "Childhood attentional dysfunctions predict social deficits in unaffected adults at risk for schizophrenia", Br J Psychiatry Suppl, pp.59~64 (1992)
- Davidson M, "Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents", Am J Psychiatry, 156, pp.1328~1335 (1999)
- Nopoulos P, "Stabil-ity of cognitive functioning early in the course of schizophrenia", Schizophr Res, 14, pp.29~37 (1994)
- Finkelstein JR, "Attention-al dysfunctions in neuroleptic-naive and neuroleptic-withdrawn schizo-phrenic patients and their siblings", J Abnorm Psychol, 106, pp.203~212 (1997)
- Gur RE, "Neurocognitive endophenotypes in a multi-plex multigenerational family study of schizophrenia", Am J Psychiatry, 164, pp.813~819 (2007)
- Snitz BE, "Cognitive deficits in un-affected first-degree relatives of schizophrenia patients: a meta-an-alytic review of putative endophenotypes", Schizophr Bull, 32, pp.179~194 (2006)
- Strauss ME, "Relations of symptoms to cognitive deficits in schizo-phrenia", Schizophr Bull, 19, pp.215~231 (1993)
- Bilder RM, "Neuropsychology of first-episode schizophrenia: initial char-acterization and clinical correlates", Am J Psychiatry, 157, pp.549~559 (2000)
- Mohamed S, "Gener-alized cognitive deficits in schizophrenia: a study of first-episode patients", Arch Gen Psychiatry, 56, pp.749~754 (1999)
- Hughes C, "Longitudinal study of symptoms and cognitive function in chronic schizophrenia", Schizophr Res, 59, pp.137~146 (2003)
- Gold S, "Longitu-dinal study of cognitive function in first-episode and recent-onset schizophrenia", Am J Psychiatry, 156, pp.1342~1348 (1999)
- Green MF, "Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria", Biol Psychiatry, 56, pp.301~307 (2004)
- Green MF, "The MATRICS initiative: developing a consensus cognitive battery for clinical trials", Schizophr Res, 72, pp.1~3 (2004)
- Nuechterlein KH, "Identification of separable cognitive factors in schizo-phrenia", Schizophr Res, 72, pp.29~39 (2004)
- 노지혜, "Factor Structure of the Neurocognitive Tests: An Application of the Confirmative Factor Analysis in Stabilized Schizophrenia Patients", Journal of Korean Medical Science, 25(2), pp.276~282 (2010), 대한의학회
- Joo EJ, "Ko-rean version of the diagnostic interview for genetic studies: Valid-ity and reliability", Compr Psychiatry, 45, pp.225~229 (2004)
- Kirkpatrick B, "The Schedule for the Deficit syndrome: an instrument for research in schizophrenia", Psychiatry Res, 30, pp.119~123 (1989)
- Guy W, "Clinical global impression scale", The ECDEU Assessment Manual for Psychopharmacology-Revised, 218~222 (1976)
- Endicott J, "The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance", Arch Gen Psychiatry, 33, pp.766~771 (1976)
- Baek JH, "Association of genetic variations in DTNBP1 with cognitive function in schizo-phrenia patients and healthy subjects", Am J Med Genet B Neuropsy-chiatr Genet, 159B, pp.841~849 (2012)
- Holtzer R, "Within-person across-neuropsychological test variability and incident dementia", JAMA, 300, pp.823~830 (2008)
- Carlsson R, "Neuropsychological functions predict 1- and 3-year outcome in first-episode psychosis", Acta Psychiatr Scand, 113, pp.102~111 (2006)
- Ventura J, "Symptoms as mediators of the relationship between neurocog-nition and functional outcome in schizophrenia: a meta-analysis", Schizophr Res, 113, pp.189~199 (2009)
- Cohen AS, "Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date", Schizophr Bull, 33, pp.1201~1212 (2007)
- Milev P, "Predictive values of neu-rocognition and negative symptoms on functional outcome in schizo-phrenia: a longitudinal first-episode study with 7-year follow-up", Am J Psychiatry, 162, pp.495~506 (2005)
- Rabinowitz J, "Negative symptoms have greater impact on function-ing than positive symptoms in schizophrenia: analysis of CATIE data", Schizophr Res, 137, pp.147~150 (2012)
- Carpenter WT Jr, "Deficit and nondefi-cit forms of schizophrenia: the concept", Am J Psychiatry, 145, pp.578~583 (1988)
- Dunayevich E, "Prevalence and description of psychot-ic features in bipolar mania", Curr Psychiatry Rep, 2, pp.286~290 (2000)
- Arai M, "As-sociation between polymorphisms in the promoter region of the si-alyltransferase 8B (SIAT8B) gene and schizophrenia", Biol Psychiatry, 59, pp.652~659 (2006)
- Vazza G, "Genome-wide scan supports the existence of a susceptibil-ity locus for schizophrenia and bipolar disorder on chromosome 15q26", Mol Psychiatry, 12, pp.87~93 (2007)
- Taylor MA, "Schneiderian first-rank symptoms and clinical prognos-tic features in schizophrenia", Arch Gen Psychiatry, 26, pp.64~67 (1972)
- Nordgaard J, "The diagnostic sta-tus of first-rank symptoms", Schizophr Bull, 34, pp.137~154 (2008)
- Lewandowski KE, "Tactile, olfactory, and gustatory hallucinations in psychotic disor-ders: a descriptive study", Ann Acad Med Singapore, 38, pp.383~385 (2009)
- Yamada N, "Age at onset of delusional dis-order is dependent on the delusional theme", Acta Psychiatr Scand, 97, pp.122~124 (1998)
